Donate For Public and Patients Store Search

F057 - Young Physician Pearls and Pitfalls: A Survival Guide For the First 10 Years

Saturday, March 2; 1:00 PM - 3:00 PM

Learning Objectives

Following this course, the attendee should be able to:

  • Determine how to incorporate mid-level providers in your practice and identify challenges that you may encounter in private practice or in an academic setting
  • Recognize the rise of private equity in our specialty and implications for the future of dermatology
  • Prepare for upcoming updates to billing and coding that will affect dermatologists at all levels

Description

This session will have key thought leaders in the field present a variety of practical topics regarding the day the day practice of dermatology most relevant to young physicians.

Disclosures

  • Brodell, Robert T., MD: Bracco – A(H); Corrona, Inc. – I(Grants/Research Funding); IntraDerm Pharmaceuticals – A(H); Novartis Pharmaceuticals Corp. – I(Grants/Research Funding); Practical Dermatology – O(H); Regeneron – A(H);
  • Elston, Dirk Michael, MD: no financial relationships exist with commercial interests.
  • Huang, William, MD: Dermatology Foundation – B(NC), I(Grants/Research Funding); DermTreat – C(NC), I(NC); Genentech, Inc. – SP(H); Gilead Sciences – I(NC); Roche Laboratories – I(NC);
  • Kaufmann, Mark D., MD: BioPharmX – C(Fees); Castle Biosciences, Inc – C(Fees); Cutanea Life Sciences – C(Fees); Dermira – C(Fees); Galderma USA – C(Fees); IntraDerm Pharmaceuticals – C(Fees); ISDIN – C(Fees); Klara/Goderma, Inc. – C(SO); L'Oreal USA Inc. – C(Fees); La Roche-Posay Laboratorie Pharmaceutique – C(Fees); Modernizing Medicine – C(SO); MoleSafe, Inc. – O(Fees), O(ST); Ortho Dermatologics – C(Fees); Promius Pharma, LLC – C(Fees); SciBASE – C(Fees); Sensus Healthcare – A(H); Sun Pharmaceutical Industries Ltd. – C(Fees); UCB – C(Fees);
  • Konda, Sailesh, MD: Gerson Lehrman Group's Council of Advisors (GLG) – C(Fees);
  • Kourosh, Arianne Shadi, MD, MPH: no financial relationships exist with commercial interests.
  • Mesinkovska, Natasha Atanaskova, MD, PhD: BiologicsMD, Inc. – C(H);
Schedule
Saturday, March 2
1:00 PM
Dr. Huang and Dr. Mesinkovska / Welcome and Introductions
1:10 PM
Dr. Kaufmann / Winds of Change: Disruption or Tsunami
1:30 PM
Dr. Brodell / The Rise of PAs/NPs: Implications for the Future
1:50 PM
Dr. Kourosh / What I Wish I Knew Then and What I Know Now
2:10 PM
Dr. Elston / Billing and Coding Updates
2:30 PM
Dr. Konda / Corporatization and the Rise of Private Equity in Dermatology
2:50 PM
Dr. Huang and Dr. Mesinkovska / Wrap Up/Panel Discussion
Event Details
  • Date
    Saturday, March 2
  • Time
    1:00 PM - 3:00 PM
  • Location
    Room 154A
  • CME Credits
    2.00
  • Type
Directors/Co-Directors
  • William Huang, MD, FAAD
  • Natasha Atanaskova Mesinkovska, MD, PhD, FAAD
Speakers
  • Arianne Shadi Kourosh, MD, MPH, FAAD
  • Dirk Michael Elston, MD, FAAD - Handout
  • Mark D. Kaufmann, MD, FAAD - Handout
  • Robert T. Brodell, MD, FAAD - Handout
  • Sailesh Konda, MD, FAAD